Statin therapy increases lipoprotein(a) levels.

Tsimikas, Sotirios; Gordts, Philip L S M; Nora, Chelsea; Yeang, Calvin; Witztum, Joseph L

Tsimikas, Sotirios; Gordts, Philip L S M; Nora, Chelsea; Yeang, Calvin; Witztum, Joseph L.

Afiliación

Tsimikas S; Vascular Medicine Program, Sulpizio Cardiovascular Center, Division of Cardiovascular Diseases, University of California San Diego, 9500 Gilman Drive, La Jolla, CA 92093-0682, USA.
Gordts PLSM; Department of Cellular and Molecular Medicine, Glycobiology Research and Training Center, University of California San Diego, 9500 Gilman Drive, La Jolla, CA 92093-0682, USA.
Nora C; Department of Medicine, Division of Endocrinology and Metabolism, University of California San Diego, 9500 Gilman Drive, La Jolla, CA 92093-0682, USA.
Yeang C; Department of Cellular and Molecular Medicine, Glycobiology Research and Training Center, University of California San Diego, 9500 Gilman Drive, La Jolla, CA 92093-0682, USA.
Witztum JL; Department of Medicine, Division of Endocrinology and Metabolism, University of California San Diego, 9500 Gilman Drive, La Jolla, CA 92093-0682, USA.

Eur Heart J ; 41(24): 2275-2284, 2020 06 21.

Article en En | MEDLINE | ID: mdl-31111151

Asunto(s)

Inhibidores de Hidroximetilglutaril-CoA Reductasas; Atorvastatina; Humanos; Lipoproteína(a); Pravastatina/uso terapéutico; Ensayos Clínicos Controlados Aleatorios como Asunto; Rosuvastatina Cálcica

Palabras clave

Aortic stenosis; Assay; Cardiovascular disease; Lipoprotein(a)

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Inhibidores de Hidroximetilglutaril-CoA Reductasas Tipo de estudio: Clinical_trials / Systematic_reviews Límite: Humans Idioma: En Revista: Eur Heart J Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google